Cellebrite DI Ltd. provides digital intelligence solutions for the public and private sectors worldwide. The company offers Cellebrite UFED, a platform for lawfully accessing and collecting digital data; Cellebrite physical analyzer, a digital data examiner; Cellebrite UFED Cloud, a platform that allow to collect, preserve, and analyze public and private-domain, social-media data, instant messaging, file storage, web pages, and other cloud-based content; Cellebrite Frontliner that collects digital evidence in real-time; Cellebrite Responder; and Cellebrite Premium. It also provides Cellebrite Seeker, a solution that collects, analysis, and reports video evidences; Cellebrite Digital Collector, a solution that allow to collect live and targeted computer data; Cellebrite pathfinder; Cellebrite Reader; Cellebrite Inspector, a computer data analysis solution; and Cellebrite Crypto Tracer that provides evidence against individuals use Bitcoin and other cryptocurrencies for money laundering, terrorism, drug and human trafficking, weapon sales, and other crimes. In addition, the company offers Cellebrite Endpoint Inspector; Cellebrite Commander; and Cellebrite Guardian, a SaaS solution for evidence management, sharing, and review that enables to manage evidence and investigative workflow. Further, it provides training and advisory; advanced digital data access and collection; technical workshops; solution deployment; crypto investigations; value realization; and technical customer support services. The company was founded in 1999 and is headquartered in Petah Tikva, Israel.
IPO Year:
Exchange: NASDAQ
Website: cellebrite.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/28/2024 | $13.00 → $13.50 | Buy | Needham |
| 3/13/2024 | Mkt Perform → Outperform | William Blair | |
| 2/16/2024 | $9.00 → $12.00 | Neutral → Buy | BofA Securities |
| 7/19/2023 | $11.00 | Buy | Craig Hallum |
| 8/12/2022 | $6.50 → $6.00 | Buy → Neutral | BofA Securities |
| 8/12/2022 | Outperform → Mkt Perform | William Blair | |
| 2/24/2022 | $10.50 | Overweight | JP Morgan |
| 2/11/2022 | $10.50 | Buy | Deutsche Bank |
| 12/29/2021 | $12.00 → $9.50 | Buy | Needham |
| 12/2/2021 | $11.00 | Buy | B of A Securities |
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2024 financial results before market open on Thursday, February 13, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the fourth quarter of 2024 and discuss its 2025 outlook. Relevant details include: Date:Thursday, February 13, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID: CLBTQ424Event URL:https://investor
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the Company will participate in the upcoming Needham & Company Growth Conference. Relevant details include: Date:January 14, 2025Conference:Needham & Company 27th Annual Growth ConferencePresentation Time:8:45 a.m. ETFormatFireside ChatEvent URL:https://investors.cellebrite.com/events/event-details/needham-co-27th-annual-growth-conferenceCellebrite Executives:Dana Gerner, chief financial officerAndrew Kramer, vice president, investor relations About Cellebrite Cellebrite's (
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company's continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company's Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. As part of Cellebrite's ongoing commitment to
Investment Round, led by Israel Growth Partners, Validates D-Fend's Disruptive Position at the Convergence of Defense Technology, Drones, Cyber, and AI RA'ANANA, Israel and MCLEAN, Va., Dec. 4, 2024 /PRNewswire/ -- D-Fend Solutions, the leader in field-proven radio frequency (RF) cyber-based, non-kinetic, non-jamming, counter-drone – takeover technology, announced today that it has secured $31M in the initial closing of a new investment round. The round was led by Israel Growth Partners (IGP), with participation from existing investor Vertex Ventures and new investor Vertex Growth. This funding underscores the critical role of D-Fend's proven innovations in enabling full control, safety, and
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- {{DATELINECITY_DATE_GLOBENEWSWIRE_BUG} Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the Company will participate in the upcoming UBS Global Technology and AI Conference. Relevant details include: Date:December 3, 2024Conference:UBS Global Technology and AI ConferencePresentation Time:4:55 p.m. ETFormatFireside ChatEvent URL:https://investors.cellebrite.com/events/event-details/ubs-global-technology-conference-0Cellebrite Executives: Thomas Hogan, executive chairman Dana Gerner, chief financial officer Andrew Krame
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier digital investigative solutions for the public and private sectors, and Relativity, a global legal technology company, announced today the general availability of the integration of Cellebrite's mobile collection solutions, Endpoint Inspector and Endpoint Mobile Now, into the RelativityOne platform. The need for mobile collection in legal processes continues to grow and this new solution makes the management of mobile data faster, more accessible and highly efficient. An Advanced Access (AA) program was conducted in July 2024 with a group of customers and
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas E. Hogan, Cellebrite's executive chairman, will serve as interim CEO upon Carmil's departure and until the search is complete and a new CEO joins Cellebrite. "Cellebrite is indebted to
Third-quarter 2024 revenue of $106.9 million exceeds $100 million quarterly revenue milestone for the first time in Company history Third-quarter 2024 revenue increased 27% year-over-year primarily due to 27% growth in subscription revenue ARR of $370.8 million, up 26% year-over-year Third-quarter 2024 adjusted EBITDA of $31.3 million, 29.3% adjusted EBITDA margin Company increases 2024 outlook for revenue and adjusted EBITDA, and raises the low end of the 2024 ARR target range TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announ
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today that Tim Tebow will keynote the Company's inaugural Case-to-Closure (C2C) User Summit, which will be held from March 31 to April 3, 2025, at the Hilton National Mall in Washington, D.C. The inaugural C2C User Summit further cements Cellebrite's position as the true end-to-end digital investigative solutions leader by bringing the brightest digital forensics minds together to discuss best practices and to obtain hands-on instruction. Tim Tebow is a two-time national football cha
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its third-quarter 2024 financial results before market open on Wednesday, November 6, 2024. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the third quarter of 2024 and discuss its 2024 outlook. Relevant details include: Date:Wednesday, November 6, 2024Time:8:30 a.m. ETCall-In Number:203-518-9766Conference ID: CLBTQ324Event URL:https://investors.cellebrite.com/events/event-det
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2024 financial results before market open on Thursday, February 13, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the fourth quarter of 2024 and discuss its 2025 outlook. Relevant details include: Date:Thursday, February 13, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID: CLBTQ424Event URL:https://investor
Third-quarter 2024 revenue of $106.9 million exceeds $100 million quarterly revenue milestone for the first time in Company history Third-quarter 2024 revenue increased 27% year-over-year primarily due to 27% growth in subscription revenue ARR of $370.8 million, up 26% year-over-year Third-quarter 2024 adjusted EBITDA of $31.3 million, 29.3% adjusted EBITDA margin Company increases 2024 outlook for revenue and adjusted EBITDA, and raises the low end of the 2024 ARR target range TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announ
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its third-quarter 2024 financial results before market open on Wednesday, November 6, 2024. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the third quarter of 2024 and discuss its 2024 outlook. Relevant details include: Date:Wednesday, November 6, 2024Time:8:30 a.m. ETCall-In Number:203-518-9766Conference ID: CLBTQ324Event URL:https://investors.cellebrite.com/events/event-det
Revenue of $95.7 million, 25% year-over-year increase primarily due to27% growth in subscription revenue;ARR of $345.9 million, up 26% year-over-year;Adjusted EBITDA of $21.6 million, 22.6% adjusted EBITDA margin;Company increases 2024 outlook for revenue and adjusted EBITDA, and raises midpoint for ARR TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in Digital Intelligence ("DI") solutions for the public and private sectors, today announced financial results for the three and six months ending June 30, 2024. "Our outstanding second-quarter 2024 performance was highlighted by significant strategic progress and strong
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 09, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its second-quarter 2024 financial results before market open on Thursday, August 15, 2024. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the second quarter of 2024 and discuss its 2024 outlook. Relevant details include: Date:Thursday, August 15, 2024Time:8:30 a.m. ETCall-In Number:203-518-9708Conference ID: CLBTQ224Event URL:https://investors.cellebrite.com/events/event-detai
ARR of $331.8 million, up 27% year-over-year; Q1 2024 revenue of $89.6 million, up 26% year-over-year primarily due to 29% growth in subscription revenue; Q1 2024 adjusted EBITDA of $17.6 million, 19.7% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 23, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three months ending March 31, 2024. "Cellebrite is off to a very solid start to 2024 as we continued to grow wallet share with existing customers around the world," said Yossi Carmil, Cellebrite's CEO. "Our strong first-quarte
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2024 financial results before market open on Thursday, May 23, 2024. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2024 and discuss its 2024 outlook. Relevant details include: Date:Thursday, May 23, 2024Time:8:30 a.m. ETCall-In Number:203-518-9783Conference ID: CLBTQ124Event URL:https://investors.cellebrite.com/events/event-
Record ARR of $315.7 million, up 27% year-over-year; Record Q4 revenue of $93.0 million, up 26% year-over-year primarily due to26% growth in subscription revenue; Record Q4 adjusted EBITDA of $22.7 million, 24.4% adjusted EBITDA margin; Full-Year 2023 performance surpasses ‘Rule of 45' with 27% ARR growth and 19% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2023. "Cellebrite capped an outstanding 2023 performance with excellen
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2023 financial results before market open on Thursday, February 15, 2024. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the fourth quarter of 2023 and discuss its 2024 outlook. Relevant details include: Date:Thursday, February 15, 2024Time:8:30 a.m. ETCall-In Number:203-518-9783Conference ID: CLBTQ423Event URL:https://investors.cellebr
Record revenue of $84.2 million, 17% year-over-year increase primarily due to 32% growth in subscription revenue; Record ARR of $295.2 million, up 27% year-over-year; Record adjusted EBITDA of $20.8 million, 24.7% Adjusted EBITDA margin; Company Increases 2023 ARR and Adjusted EBITDA Outlook, and Raises Mid-Point for Expected 2023 Revenue Range TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in Digital Intelligence ("DI") solutions for the public and private sectors, today announced financial results for the three and nine months ending September 30, 2023. "I am pleased with Cellebrite's third-quarter 2023 perfor
SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13G - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13G - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13D - Cellebrite DI Ltd. (0001854587) (Subject)
144 - Cellebrite DI Ltd. (0001854587) (Subject)
6-K - Cellebrite DI Ltd. (0001854587) (Filer)
144 - Cellebrite DI Ltd. (0001854587) (Subject)
144 - Cellebrite DI Ltd. (0001854587) (Subject)
144 - Cellebrite DI Ltd. (0001854587) (Subject)
144 - Cellebrite DI Ltd. (0001854587) (Subject)
6-K - Cellebrite DI Ltd. (0001854587) (Filer)
6-K - Cellebrite DI Ltd. (0001854587) (Filer)
6-K - Cellebrite DI Ltd. (0001854587) (Filer)
6-K - Cellebrite DI Ltd. (0001854587) (Filer)
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company's continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company's Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. As part of Cellebrite's ongoing commitment to
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas E. Hogan, Cellebrite's executive chairman, will serve as interim CEO upon Carmil's departure and until the search is complete and a new CEO joins Cellebrite. "Cellebrite is indebted to
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier digital investigative solutions for the public and private sectors, announced today that Troy Richardson has joined its board of directors, effective August 13, 2024. Mr. Richardson is a seasoned technology executive with more than 30 years of experience in leading, scaling and transforming global organizations. He currently serves on the Unisys Corporation (NYSE:UIS) Board of Directors and previously served as a Director of the Board for Carestream Dental. Mr. Richardson was president of the Digital Thread group at PTC Inc. (NASDAQ:PTC) from 2021 until 2022
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the appointment of Sigalit Shavit as Chief Information Officer (CIO) who begins her role today, August 1, 2024. Shavit joins the Company's Leadership Team, bringing with her more than 30 years of experience to Cellebrite's information technology and security team. In this newly established position that reports to CEO Yossi Carmil, Shavit will play a pivotal role in scaling the Company's ability to innovate and support customers as they strive to continue accelerating justice a
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a leader in digital investigative solutions for the public and private sectors, officially established Cellebrite Federal Solutions, further elevating the Company's ability to serve the unique needs of the U.S. federal government through its AI-driven Case-to-Closure [C2C] platform for accelerating justice. This newly established operation builds on the Company's long and rich history of serving U.S. justice, defense, intelligence and other federal civilian agencies with its world-renowned Case-to-Closure platform, assisting in critical initiatives targeting the safety and protection
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 25, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd (NASDAQ:CLBT), a global leader in Digital Investigative solutions for the public and private sectors, today announced the appointment of David Gee as Chief Marketing Officer (CMO). Mr. Gee brings more than 25 years of global sales and marketing expertise and will serve as a member of Cellebrite's executive leadership team, reporting directly to CEO Yossi Carmil. He will oversee Cellebrite's global marketing strategy and execution to help the Company capitalize on the major growth opportunities ahead in the digital investigations marketplace. Mr. Gee joins Cellebrite as digital crimes escalate
BOUNTIFUL, UT / ACCESSWIRE / December 18, 2023 / OneMeta Inc. (www.onemeta.ai) (OTC:ONEI).OneMeta, Inc., the most innovative and advanced provider of AI-powered translation and transcription, has appointed Thomas E. Hogan as the newest member of its Board of Directors.Mr. Hogan brings a remarkable 40+ year track record of delivering exceptional shareholder returns, social impact, and rapid growth. He has significant expertise in sales and marketing, international operations, and talent acquisition and development. His career includes decades as both a private and publicly held software CEO as well as senior executive positions ranging from late stage private to mega-cap public companies.Tom
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 14, 2023 (GLOBE NEWSWIRE) -- In a move that signals international momentum and market leadership, Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, announced today the appointment of Marcus Jewell as Global Chief Revenue Officer (CRO), effective November 15, 2023. As CRO, Mr. Jewell will oversee worldwide sales for both the public and private sectors in support of the Company's strategic priorities. Together with the executive leadership team, Jewell will operate from Cellebrite's American headquarters in Tysons Corner, Virginia, and report directly into CEO Yossi C
Seasoned Technology Leader to Partner with CEO Yossi Carmil to Further Company Growth and Strategic Priorities TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, announced today that proven industry veteran, Thomas E. Hogan has been appointed Executive Chairman of the Board. Based in Austin, Texas, Hogan brings a remarkable 40+ year track record of exceptional shareholder returns, client impact, and employee growth. He has significant expertise in strategic M&A, sales and marketing, international operations, and talent acquisition and dev
PETAH TIKVA, Israel and TYSONS CORNER, Va., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, today announced that Ayala Berler Shapira has been named General Counsel (GC) of the company. As part of the company's further growth Ayala Berler Shapira will strategically manage all legal aspects and will assume complete responsibility and lead the legal and compliance organization of Cellebrite. She will be a member of Cellebrite's executive management team. Ayala brings 27 years of experience in both global technology companies and in some of the leading law firms in Israel. Prior to
Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $13.50 from $13.00 previously
William Blair upgraded Cellebrite DI from Mkt Perform to Outperform
BofA Securities upgraded Cellebrite DI from Neutral to Buy and set a new price target of $12.00 from $9.00 previously
Craig Hallum initiated coverage of Cellebrite DI with a rating of Buy and set a new price target of $11.00
BofA Securities downgraded Cellebrite DI from Buy to Neutral and set a new price target of $6.00 from $6.50 previously
William Blair downgraded Cellebrite DI from Outperform to Mkt Perform
JP Morgan initiated coverage of Cellebrite DI with a rating of Overweight and set a new price target of $10.50
Deutsche Bank initiated coverage of Cellebrite DI with a rating of Buy and set a new price target of $10.50
Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $9.50 from $12.00 previously
B of A Securities initiated coverage of Cellebrite DI with a rating of Buy and set a new price target of $11.00